About
Orthonika is a private limited company founded in 2014 as a spin-out from Imperial College London. The company specializes in advanced orthopedic solutions, particularly focusing on the development and commercialization of the Total Meniscus Replacement (TMR) implant. This innovative implant is designed to treat irreparable meniscal injuries in the knee, aiming to replicate the biomechanics of a natural meniscus. The TMR implant addresses a significant clinical need, as over 2 million meniscus interventions occur annually worldwide, with many injuries deemed irreparable. Orthonika combines expertise in biomechanics, biomaterials, and material science to create a fully synthetic anatomical meniscus that helps reduce knee pain and restore mobility. The company’s leadership in product design and development is guided by CTO Maria Kristina Bartolo, who has played a key role in advancing the TMR technology. Orthonika primarily serves orthopedic surgeons and healthcare providers specializing in joint care and knee surgery, offering improved treatment options for patients with meniscal damage. The company is headquartered in London, United Kingdom.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2014
-
Total Funding $3440869
Location
168 Shoreditch High Street, London, England, United Kingdom, E1 6HU
